NeoGenomics (NEO) Sɔɔtɔ Fɔrɛkɛst
NeoGenomics
Nɔnyɔ nyɛ$19.33Nɔɔ 25 Gbo 2026 19:59 UTC
Nyuɛ-1.23%
AI forecast: NEO
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
NeoGenomics, Inc. operates a network of clinical laboratories specializing in diagnostic testing for hereditary cancer. The company’s services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing.
